"Ensuring affordable and quality healthcare to the people is the government's priority. We are committed to achieving zero tuberculosis deaths. Therefore, we need to re-strategise, think afresh and be aggressive in our approach to end TB by 2025," he said at a programme here.
"The National Strategic Program (NSP) will be finalised in a month and will be rolled out across the country. The vision of NSP is a TB-Free India. This programme aims at rapid decline of the tuberculosis burden," Nadda said.
The minister said the 'Active Case Findings' initiative, which was launched in January in 17 states and covered 50 districts in the first phase to treat TB among vulnerable population groups, will be rolled out in 130 other districts by the end of this year.
"We are going ahead with Active Case Findings with better preparation in 130 more selected High Risk districts to bring TB cases under treatment early. This would reduce the number of deaths, transmission of the disease and also its drug-resistant variant," he said.
Nadda also said the 'Daily Regimen' which have been found to be more effective and is till now is being implemented in five states will be rolled out across the country this year.
Observing that India has the highest number of TB cases in the world, he said the government has heightened its action to meet the 'End TB 'target by 2025.
"Drug-resistant TB is a growing threat and its diagnosis and treatment is costlier. We have decided to attack the root cause of the disease head-on," Nadda said.
Informing that the government has made notification of TB cases mandatory, he said, "Almost 92 per cent of TB patients with HIV has been put on antiretroviral therapy."
"The government has distributed more than 500 CBNAAT machines for rapid quality diagnostics in a year, with at least one such machine for each district. This step has led to 35 per cent rise in notification of drug-resistant TB cases last year," Nadda said.
At the event, the minister launched 'India vs TB', a campaign for early identification of tuberculosis symptoms propagating the importance of its treatment. The campaign features Bollywood star Amitabh Bachchan.
The campaign has been developed by International Union Against Tuberculosis and Lung Disease supported by the United States Agency for International Development (USAID), Challenge TB.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)